Page last updated: 2024-08-24

sertraline and AIDS-Related Opportunistic Infections

sertraline has been researched along with AIDS-Related Opportunistic Infections in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bangdiwala, AS; Boulware, DR; Hullsiek, KH; Kirumira, P; Meya, DB; Nalintya, E; Naluyima, R; Namanda, S; Nikweri, Y; Rajasingham, R; Rutakingirwa, MK; Skipper, CP; Turya, F1
Boulware, DR; Meya, DB; Rajasingham, R1
Camacho-Ortiz, A; Castillo-Reyna, L; Galindo-Alvarado, SG; González, GM; Hernández-Rodríguez, PA; Martínez-Reséndez, MF; Treviño-Rangel, RJ; Villanueva-Lozano, H1
Abassi, M; Akampurira, A; Alhadab, A; Bahr, NC; Boulware, DR; Fisher, J; Hullsiek, KH; Kiggundu, R; Meya, DB; Morawski, BM; Musubire, A; Nabeta, HW; Nielsen, K; Rhein, J; Smith, KD; Tugume, L; Velamakanni, SS; Williams, DA1
Abassi, M; Boulware, DR; Lofgren, S; Rhein, J1

Reviews

1 review(s) available for sertraline and AIDS-Related Opportunistic Infections

ArticleYear
Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
    Expert review of anti-infective therapy, 2017, Volume: 15, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Asymptomatic Diseases; Cost-Benefit Analysis; Cryptococcus neoformans; Developing Countries; Drug Administration Schedule; Fluconazole; Humans; Mass Screening; Meningitis, Cryptococcal; Sertraline

2017

Trials

3 trial(s) available for sertraline and AIDS-Related Opportunistic Infections

ArticleYear
Adjunctive sertraline for asymptomatic cryptococcal antigenemia: A randomized clinical trial.
    Medical mycology, 2020, Nov-10, Volume: 58, Issue:8

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antigens, Fungal; Asymptomatic Infections; Cryptococcosis; Cryptococcus; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Serotonin Syndrome; Sertraline

2020
Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience.
    Infection, 2018, Volume: 46, Issue:1

    Topics: Adjuvants, Pharmaceutic; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Double-Blind Method; Female; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Mexico; Middle Aged; Prospective Studies; Sertraline; Tertiary Care Centers; Young Adult

2018
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.
    The Lancet. Infectious diseases, 2016, Volume: 16, Issue:7

    Topics: Adult; AIDS-Related Opportunistic Infections; Antidepressive Agents; Cryptococcus; Female; HIV Infections; Humans; Incidence; Male; Meningitis, Cryptococcal; Sertraline; Treatment Outcome

2016

Other Studies

1 other study(ies) available for sertraline and AIDS-Related Opportunistic Infections

ArticleYear
Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?
    HIV medicine, 2018, Volume: 19, Issue:6

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotics, Antitubercular; Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; HIV Infections; Humans; Mycoses; Rifampin; Sertraline; Tuberculosis

2018